Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
917.90
3.05 (0.33%)
< Home < Back

Natco Pharma - Quaterly Results

Date: 12-08-2025
A slight decline in the revenue of Rs. 11927.00 millions was seen for the June 2025 quarter as against Rs. 12369.00 millions during year-ago period.The Net Profit of the company registered a slight decline of -27.06% to Rs. 4641.00  millions from Rs. 6363.00 millions.The Operating Profit of the company witnessed a decrease to 5993.00 millions from 8028.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 11927.00 12369.00 -3.57 11927.00 12369.00 -3.57 40945.00 35689.00 14.73
Other Income 596.00 398.00 49.75 596.00 398.00 49.75 3213.00 1047.00 206.88
PBIDT 5993.00 8028.00 -25.35 5993.00 8028.00 -25.35 24656.00 17417.00 41.56
Interest 26.00 44.00 -40.91 26.00 44.00 -40.91 196.00 145.00 35.17
PBDT 5967.00 7984.00 -25.26 5967.00 7984.00 -25.26 24460.00 17272.00 41.62
Depreciation 538.00 404.00 33.17 538.00 404.00 33.17 2200.00 1719.00 27.98
PBT 5429.00 7580.00 -28.38 5429.00 7580.00 -28.38 22260.00 15553.00 43.12
TAX 788.00 1217.00 -35.25 788.00 1217.00 -35.25 3756.00 2487.00 51.03
Deferred Tax -272.00 -107.00 154.21 -272.00 -107.00 154.21 -319.00 -361.00 -11.63
PAT 4641.00 6363.00 -27.06 4641.00 6363.00 -27.06 18504.00 13066.00 41.62
Equity 358.00 358.00 0.00 358.00 358.00 0.00 358.00 358.00 0.00
PBIDTM(%) 50.25 64.90 -22.58 50.25 64.90 -22.58 60.22 48.80 23.39